VG Life Sciences Inc.
VGLS
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 27.54% | 4.38% | -244.52% | 60.07% | 46.79% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -45.34% | -44.03% | 12.07% | 15.66% | -12.25% |
| Total Other Non-Cash Items | -5.06% | -6.43% | 42.65% | -16.13% | -28.03% |
| Change in Net Operating Assets | -0.80% | 129.22% | 115.99% | -183.39% | -159.74% |
| Cash from Operations | 79.67% | -44.00% | 59.50% | 13.00% | -51.60% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -63.16% | 23.81% | -53.81% | -17.20% | 159.01% |
| Total Debt Repaid | 30.82% | 0.00% | -29.17% | -350.00% | -308.70% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -68.41% | 31.47% | -58.44% | -20.78% | 153.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.37% | -558.97% | 80.40% | -194.76% | 118.13% |
